Simpler Grants.gov #HT942526DMDRPCTRA

Army Duchenne Muscular Dystrophy Clinical/Translational Research Grant Opportunity

This opportunity is a grant solicitation from the Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA), for advanced translational research in Duchenne muscular dystrophy (DMD): - Government Buyer: - Department of the Army - US Army Medical Research Acquisition Activity (USAMRAA) - Managed by Congressionally Directed Medical Research Programs (CDMRP) - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a research grant opportunity - Products/Services Requested: - Clinical/Translational Research in Duchenne muscular dystrophy - Includes preclinical and clinical studies, pilot clinical trials, and clinical trial readiness studies - Two funding levels: - Level 1: Smaller, less complex research - Level 2: Larger, more complex research - Partnering PI Option (PPIO) available for collaborative projects - Unique/Notable Requirements: - Preliminary data required for all applications - Must address at least one FY26 CTRA Focus Area - Therapies effective across the lifespan are encouraged - Both early-career and established interdisciplinary researchers are eligible - Approximately 6 awards anticipated, with total program funding of $8,460,000

Description

The fiscal year 2026 Duchenne Muscular Dystrophy Research Program Clinical/Translational Research Award supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas and projects investigating therapies efficacious across the lifespan are encouraged. The award offers two funding levels for smaller or larger preclinical and/or clinical research and includes a Partnering PI Option to support collaborations between investigators. Preliminary data are required, and pilot clinical trials and clinical trial readiness studies are allowed.

View original listing